MA
ARKG icon

MBA Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

MBA Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
+6,430
New +$205K 0.09% 128
2021
Q2 		– Sell
-2,268
Closed -$201K – 137
2021
Q1 		$201K Buy
+2,268
New +$225K 0.11% 130

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MBA Advisors's ARKG Position: Q2 2026 in Review

MBA Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,430 shares worth $270K. The stake represents 0.09% of the portfolio and ranks #128 among its holdings. This is a return to the name: MBA Advisors previously reported a position in ARKG as recently as Q1 2021.

MBA Advisors first reported a position in ARKG in Q1 2021 and has held it in 2 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • MBA Advisors held 6,430 shares of ARK Genomic Revolution ETF worth $270K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new MBA Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.09% of MBA Advisors's portfolio in Q2 2026, its #128 holding.
  • MBA Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 2 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on MBA Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.